Mainolfi Nello
SEC CIK 1821189 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| KYMR | Kymera Therapeutics, Inc. | CEO, Dir | 716.6K | — | $47.00M | 44 | 2021-07-08 | 2026-07-07 |
Most active insiders at KYMR, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Booth Bruce | Dir | — | $226.03M |
| 2 | BVF PARTNERS L P/IL | Dir, See Remarks, Footnotes | — | $173.67M |
| 3 | BAKER FELIX | Dir, 10% | $172.50M | — |
| 4 | Mainolfi Nello | CEO, Dir | — | $33.41M |
| 5 | Chadwick Jeremy G | COO | — | $15.60M |
| 6 | Jacobs Bruce N. | CFO | — | $9.96M |
| 7 | Gollob Jared | Chief Medical Off | — | $9.13M |
| 8 | Esposito Pamela | Dir | — | $3.05M |
| 9 | Goodman Noah | Chief Business Off | — | $2.22M |
| 10 | Ridloff Elena | Dir | — | $1.29M |
Transactions 44
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-07-07 20:00 | 2026-07-07 | KYMR | Kymera Therapeutics, Inc. | Mainolfi Nello | CEO, Dir | M - OptEx | $2.08 | +50.0K | 716.6K | +8% | +$104.0K |
| DT | 2026-07-07 20:00 | 2026-07-07 | KYMR | Kymera Therapeutics, Inc. | Mainolfi Nello | CEO, Dir | S - Sale+OE | $119.00 | -50.0K | 666.6K | -7% | -$5.95M |
| DT | 2026-07-02 18:30 | 2026-07-01 | KYMR | Kymera Therapeutics, Inc. | Mainolfi Nello | CEO, Dir | M - OptEx | $2.08 | +80.0K | 746.6K | +12% | +$166.4K |
| DMT | 2026-07-02 18:30 | 2026-07-01 | KYMR | Kymera Therapeutics, Inc. | Mainolfi Nello | CEO, Dir | S - Sale+OE | $115.29 | -80.0K | 666.6K | -11% | -$9.22M |
| DT | 2026-04-29 17:00 | 2026-04-29 | KYMR | Kymera Therapeutics, Inc. | Mainolfi Nello | CEO, Dir | M - OptEx | $2.08 | +30.0K | 696.2K | +5% | +$62.4K |
| DMT | 2026-04-29 17:00 | 2026-04-29 | KYMR | Kymera Therapeutics, Inc. | Mainolfi Nello | CEO, Dir | S - Sale+OE | $81.18 | -30.0K | 666.2K | -4% | -$2.44M |
| DMT | 2026-02-25 | 2026-02-25 | KYMR | Kymera Therapeutics, Inc. | Mainolfi Nello | CEO, Dir | S - Sale+OE | $90.26 | -30.0K | 671.0K | -4% | -$2.71M |
| DT | 2026-02-25 | 2026-02-25 | KYMR | Kymera Therapeutics, Inc. | Mainolfi Nello | CEO, Dir | M - OptEx | $2.08 | +30.0K | 696.2K | +5% | +$62.4K |
| D | 2026-01-06 | 2026-01-05 | KYMR | Kymera Therapeutics, Inc. | Mainolfi Nello | CEO, Dir | M - OptEx | $32.07 | +3,118 | 666.2K | +0.5% | +$100.0K |
| DT | 2025-12-31 | 2025-12-31 | KYMR | Kymera Therapeutics, Inc. | Mainolfi Nello | CEO, Dir | M - OptEx | $2.08 | +30.0K | 693.1K | +5% | +$62.4K |
| DMT | 2025-12-31 | 2025-12-31 | KYMR | Kymera Therapeutics, Inc. | Mainolfi Nello | CEO, Dir | S - Sale+OE | $78.06 | -30.0K | 669.1K | -4% | -$2.34M |
| D | 2025-12-17 | 2025-12-17 | KYMR | Kymera Therapeutics, Inc. | Mainolfi Nello | CEO, Dir | M - OptEx | $38.53 | +2,595 | 663.1K | +0.4% | +$100.0K |
| DT | 2025-12-08 | 2025-12-08 | KYMR | Kymera Therapeutics, Inc. | Mainolfi Nello | CEO, Dir | M - OptEx | $2.08 | +100.0K | 760.5K | +15% | +$208.0K |
| DT | 2025-12-08 | 2025-12-08 | KYMR | Kymera Therapeutics, Inc. | Mainolfi Nello | CEO, Dir | S - Sale+OE | $89.17 | -100.0K | 660.5K | -13% | -$8.92M |
| DT | 2025-10-29 | 2025-10-29 | KYMR | Kymera Therapeutics, Inc. | Mainolfi Nello | CEO, Dir | M - OptEx | $2.08 | +30.0K | 690.5K | +5% | +$62.4K |
| DMT | 2025-10-29 | 2025-10-29 | KYMR | Kymera Therapeutics, Inc. | Mainolfi Nello | CEO, Dir | S - Sale+OE | $60.99 | -30.0K | 664.1K | -4% | -$1.83M |
| DT | 2025-09-16 | 2025-09-16 | KYMR | Kymera Therapeutics, Inc. | Mainolfi Nello | CEO, Dir | S - Sale+OE | $49.00 | -30.0K | 660.5K | -4% | -$1.47M |
| DT | 2025-09-16 | 2025-09-16 | KYMR | Kymera Therapeutics, Inc. | Mainolfi Nello | CEO, Dir | M - OptEx | $2.08 | +30.0K | 690.5K | +5% | +$62.4K |
| DT | 2025-06-03 | 2025-06-03 | KYMR | Kymera Therapeutics, Inc. | Mainolfi Nello | CEO, Dir | M - OptEx | $2.08 | +30.0K | 690.5K | +5% | +$62.4K |
| DT | 2025-06-03 | 2025-06-03 | KYMR | Kymera Therapeutics, Inc. | Mainolfi Nello | CEO, Dir | S - Sale+OE | $49.00 | -30.0K | 660.5K | -4% | -$1.47M |
| D | 2025-01-13 | 2025-01-10 | KYMR | Kymera Therapeutics, Inc. | Mainolfi Nello | CEO, Dir | M - OptEx | $2.08 | +10.0K | 660.0K | +2% | +$20.8K |
| D | 2024-07-01 | 2024-07-01 | KYMR | Kymera Therapeutics, Inc. | Mainolfi Nello | CEO, Dir | M - OptEx | $5.33 | +18.8K | 650.0K | +3% | +$100.1K |
| D | 2024-06-20 | 2024-06-18 | KYMR | Kymera Therapeutics, Inc. | Mainolfi Nello | CEO, Dir | M - OptEx | $2.08 | +14.4K | 631.2K | +2% | +$30.0K |
| D | 2024-01-02 | 2024-01-02 | KYMR | Kymera Therapeutics, Inc. | Mainolfi Nello | CEO, Dir | M - OptEx | $2.08 | +9,000 | 615.6K | +1% | +$18.7K |
| DM | 2023-11-06 | 2023-11-03 | KYMR | Kymera Therapeutics, Inc. | Mainolfi Nello | CEO, Dir | M - OptEx | $2.08 | +20.0K | 606.6K | +3% | +$41.6K |
| D | 2023-08-08 | 2023-08-08 | KYMR | Kymera Therapeutics, Inc. | Mainolfi Nello | CEO, Dir | M - OptEx | $2.08 | +12.0K | 586.6K | +2% | +$25.0K |
| D | 2022-12-08 | 2022-12-08 | KYMR | Kymera Therapeutics, Inc. | Mainolfi Nello | CEO, Dir | M - OptEx | $2.08 | +10.0K | 573.7K | +2% | +$20.8K |
| DM | 2022-10-17 | 2022-10-17 | KYMR | Kymera Therapeutics, Inc. | Mainolfi Nello | CEO, Dir | M - OptEx | $2.08 | +59.7K | 561.9K | +12% | +$124.2K |
| D | 2022-05-03 | 2022-05-03 | KYMR | Kymera Therapeutics, Inc. | Mainolfi Nello | CEO, Dir | M - OptEx | $2.08 | +20.0K | 502.2K | +4% | +$41.6K |
| D | 2022-01-14 | 2022-01-14 | KYMR | Kymera Therapeutics, Inc. | Mainolfi Nello | CEO, Dir | M - OptEx | $2.08 | +10.0K | 482.2K | +2% | +$20.8K |
| DM | 2022-01-12 | 2022-01-10+ | KYMR | Kymera Therapeutics, Inc. | Mainolfi Nello | CEO, Dir | M - OptEx | $2.08 | +48.0K | 489.1K | +11% | +$99.8K |
| DM | 2022-01-12 | 2022-01-10+ | KYMR | Kymera Therapeutics, Inc. | Mainolfi Nello | CEO, Dir | S - Sale+OE | $53.31 | -48.0K | 472.2K | -9% | -$2.56M |
| D | 2021-12-16 | 2021-12-16 | KYMR | Kymera Therapeutics, Inc. | Mainolfi Nello | CEO, Dir | M - OptEx | $2.08 | +8,000 | 472.2K | +2% | +$16.6K |
| DM | 2021-10-12 | 2021-10-08+ | KYMR | Kymera Therapeutics, Inc. | Mainolfi Nello | CEO, Dir | S - Sale+OE | $56.34 | -48.0K | 475.1K | -9% | -$2.70M |
| DM | 2021-10-12 | 2021-10-08+ | KYMR | Kymera Therapeutics, Inc. | Mainolfi Nello | CEO, Dir | M - OptEx | $2.08 | +48.0K | 505.7K | +10% | +$99.8K |
| D | 2021-08-19 | 2021-08-19 | KYMR | Kymera Therapeutics, Inc. | Mainolfi Nello | CEO, Dir | M - OptEx | $2.08 | +12.0K | 464.2K | +3% | +$25.0K |
| DM | 2021-08-05 | 2021-08-03+ | KYMR | Kymera Therapeutics, Inc. | Mainolfi Nello | CEO, Dir | S - Sale+OE | $60.06 | -6,706 | 452.2K | -1% | -$402.8K |
| DM | 2021-08-05 | 2021-08-03+ | KYMR | Kymera Therapeutics, Inc. | Mainolfi Nello | CEO, Dir | M - OptEx | $2.08 | +6,706 | 457.9K | +1% | +$13.9K |
| DM | 2021-08-02 | 2021-07-29+ | KYMR | Kymera Therapeutics, Inc. | Mainolfi Nello | CEO, Dir | S - Sale+OE | $60.25 | -30.4K | 452.2K | -6% | -$1.83M |
| DM | 2021-08-02 | 2021-07-29+ | KYMR | Kymera Therapeutics, Inc. | Mainolfi Nello | CEO, Dir | M - OptEx | $2.08 | +30.4K | 475.7K | +7% | +$63.3K |
| DM | 2021-07-28 | 2021-07-26+ | KYMR | Kymera Therapeutics, Inc. | Mainolfi Nello | CEO, Dir | M - OptEx | $2.08 | +12.9K | 456.1K | +3% | +$26.8K |
| DM | 2021-07-28 | 2021-07-26+ | KYMR | Kymera Therapeutics, Inc. | Mainolfi Nello | CEO, Dir | S - Sale+OE | $60.15 | -12.9K | 452.2K | -3% | -$774.7K |
| DM | 2021-07-09 | 2021-07-08 | KYMR | Kymera Therapeutics, Inc. | Mainolfi Nello | CEO, Dir | S - Sale+OE | $49.70 | -48.0K | 452.2K | -10% | -$2.39M |
| D | 2021-07-09 | 2021-07-08 | KYMR | Kymera Therapeutics, Inc. | Mainolfi Nello | CEO, Dir | M - OptEx | $2.08 | +48.0K | 500.2K | +11% | +$99.8K |
Purchase Sale Sale after option exercise All abbreviations